Amy E. Herr sold $64k of TECH
director at BIO-TECHNE Corp. 1,280 shares at an average of $49.77, traded Jun 9, 2025, filed Jun 11, 2025.
Score components
- +15RoleDirector
- +8Trade size$64k at market
- +10Share of holdings soldSold 39% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-011400, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 9, 2025 | MOption exercise Common Stockindirect: By significant other | +1,280 | $44.33 | $57k | 3,256 | Jun 11, 2025 |
| Jun 9, 2025 | SOpen-market sale Common Stockindirect: By significant other | -1,280 | $49.77 | $64k | 1,976 | Jun 11, 2025 |
| Jun 9, 2025 | MOption exercise Stock Option (Right to Buy)derivativeindirect: By significant other | -1,280 | $0.00 | $0 | 0 | Jun 11, 2025 |
Related signals
Other insiders at BIO-TECHNE Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | BIO-TECHNE Corp | Robert Baumgartner V director | $958k 17,040 shares | -28% | |
| 42Moderate | BIO-TECHNE Corp | Roeland Nusse director | $960k 17,040 shares | -28% | |
| 20Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $123k 1,860 shares | -48% | |
| 45Moderate | TECHsell BIO-TECHNE Corp | Kim Kelderman Chief Executive Officer | $1.0M 13,392 shares | -26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.